Rituximab (Rituxan/MabThera)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rituximab (Rituxan/MabThera), covering 2016-11-02 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma [Phase 2]